|
|
| Phases of Development | Discovery | Preclinical | IND | Pilot | Phase I | Phase I/II | Phase II | Phase II/III | Pivotal | Phase III | Registration | Approved | Marketed |
|---|
| Autoimmune | 1 | 3 | 0 | 0 | 0 | 1 | 3 | 0 | 0 | 2 | 0 | 0 | 0 | | Cancer | 0 | 8 | 0 | 0 | 12 | 11 | 14 | 1 | 0 | 9 | 1 | 4 | 6 | | Cardiovascular | 0 | 8 | 0 | 3 | 3 | 6 | 8 | 0 | 1 | 0 | 0 | 2 | 3 | | Dental | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 2 | | Dermatology | 0 | 2 | 0 | 0 | 2 | 0 | 1 | 0 | 0 | 2 | 0 | 1 | 4 | | Diagnostic | 2 | 1 | 1 | 3 | 0 | 0 | 4 | 0 | 3 | 1 | 5 | 25 | 134 | | Endocrine / Metabolic | 0 | 2 | 0 | 0 | 1 | 3 | 3 | 0 | 0 | 1 | 2 | 0 | 5 | | Gastrointestinal | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 1 | 0 | 0 | 3 | | Genitourinary | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 2 | 0 | 0 | 0 | | Hematology | 0 | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 0 | 1 | 0 | 0 | 8 | | Hepatic | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | | Infectious | 0 | 16 | 0 | 0 | 15 | 5 | 25 | 0 | 0 | 3 | 2 | 9 | 37 | | Inflammation | 0 | 3 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 5 | | Musculoskeletal | 0 | 1 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 5 | 10 | | Neurology | 0 | 6 | 1 | 0 | 6 | 2 | 8 | 1 | 0 | 2 | 0 | 0 | 1 | | Ophthalmic | 0 | 3 | 0 | 0 | 1 | 2 | 4 | 0 | 0 | 0 | 0 | 1 | 2 | | Other | 0 | 2 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 2 | | Pulmonary | 0 | 2 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | | Renal | 0 | 2 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 1 | 1 | | Transplant | 0 | 2 | 1 | 0 | 2 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 0 |
|
|
Products Targeting Not applicable